Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer

被引:30
|
作者
Tang, Yang [1 ]
Zhu, Jinwei [1 ]
Chen, Ling [3 ]
Chen, Linyin [2 ]
Zhang, Sheng [2 ]
Lin, Jianyin [1 ]
机构
[1] Fujian Med Univ, Res Ctr Mol Med, Key Lab Infect & Oncol, Fuzhou 350001, Peoples R China
[2] Fujian Med Univ, Dept Pathol, Affiliated Hosp 1, Fuzhou 350001, Peoples R China
[3] Fujian Med Univ, Affiliated Union Hosp, Inst Clin Immunol, Fuzhou 350001, Peoples R China
关键词
D O I
10.1158/1078-0432.CCR-07-4042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Like most cancers, gastric cancer has a complex multistep etiology that involves both environmental and genetic factors. Matrix metalloproteinase-9 (MMP-9) is frequently over-expressed in gastric cancer. We investigated the effect of the genetic differences in MMP-9 coding region on the occurrence and progression of gastric cancer. Experimental Design: A case-control study was conducted in a population of 74 patients and 100 healthy people in southeast China. Individuals were genotyped for two single nucleotide polymorphisms (SNP) in MMP-9: R279Q and P574R. Genotypic distributions between patient and control groups were compared for correlations with cancer occurrence. Associations between genotypic distributions and several clinicopathologic features were also analyzed using univariate tests, multivariate logistic regression modeling, and stratified analyses. Results: Significant associations were revealed between both SNPs and lymph node metastasis [P = 0.012 and 0.025; odds ratio (OR), 3.4 and 2.8, respectively]. After adjustment using logistic regression for the potential confounding effects of gender, age, and location of the tumors, homozygous MMP-9 279RR and 574PP are more evidently associated with lymph node metastasis with ORadjusted of 5.7 [95% confidence interval (95% CI), 1.80-18.34] and 4.2 (95% CI, 1.37-12.69). The homozygous 279R-574P haplotype showed a stronger association by an ORadjusted of 6.1 (95% CI, 1.92-12.29) and was also associated with the 1-year postoperative mortality (ORadjusted, 6.5; 95% CI, 1.18-35.74). Interestingly, our data also suggested that the MMP-9 polymorphisms seem to result in higher risk of lymph node metastasis through a pathway independent of cancer invasion because no positive associations were found between these polymorphisms and cancer invasion (OR, 0.59 < 1). The stratified analyses indicated a synergistic interaction between the MMP-9 polymorphisms and the type of diffuse in affecting lymph node metastasis (OR, 13.4; P-between (strata) = 0.04). Significant association between both SNPs and the overall occurrence of gastric cancer was not observed. Conclusion:The present study has shown significant associations between the two nonsynonymous MMP-9 polymorphisms with lymph node metastasis in gastric cancer, especially with the diffuse type. The relatively large values of ORs and disassociation with cancer invasion suggest that the genetic differences of MMP-9 protein play an important and specific role in lymph node metastases, and therefore, further investigation of the underlying molecular mechanism is warranted.
引用
收藏
页码:2870 / 2877
页数:8
相关论文
共 50 条
  • [2] Serum levels of matrix metalloproteinase-9 predict lymph node metastasis in breast cancer patients
    Heo, Dong Sik
    Choi, Hoon
    Yeom, Mi Young
    Song, Byung Joo
    Oh, Se Jeong
    ONCOLOGY REPORTS, 2014, 31 (04) : 1567 - 1572
  • [3] Overexpression of Twist and Matrix Metalloproteinase-9 with Metastasis and Prognosis in Gastric Cancer
    Gao, Xing-Hui
    Yang, Xue-Qin
    Wang, Bi-Cheng
    Liu, Shao-Ping
    Wang, Fu-Bing
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (09) : 5055 - 5060
  • [4] Expression of Matrix Metalloproteinase-9 in Gastric Cancer
    Prathipaa, R.
    Priyathersini, N.
    Thanka, J.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [5] Matrix metalloproteinase-9 mediates growth, invasion, and metastasis of human breast cancer cells
    Mehner, Christine
    Miller, Erin
    Radisky, Derek C.
    Radisky, Evette S.
    CANCER RESEARCH, 2011, 71
  • [6] Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer
    Hu, ZB
    Huo, X
    Lu, DR
    Qian, J
    Zhou, JN
    Chen, YJ
    Xu, L
    Ma, HX
    Zhu, MF
    Wei, QY
    Shen, HB
    CLINICAL CANCER RESEARCH, 2005, 11 (15) : 5433 - 5439
  • [7] The association of matrix metalloproteinase-9 promoter polymorphisms with gastric cancer risk: a meta-analysis
    Peng, Ziheng
    Jia, Jinhai
    Gong, Wenjian
    Gao, Xuehan
    Ma, Peiru
    Jin, Zhucheng
    Fan, Yue
    Li, Yanchu
    Zhang, Xiaolin
    ONCOTARGET, 2017, 8 (58) : 99024 - 99032
  • [8] Membrane-type 1 matrix metalloproteinase enhances lymph node metastasis of gastric cancer
    Yonemura, Y
    Endo, Y
    Takino, T
    Sakamoto, K
    Bandou, E
    Kinoshita, K
    Fushida, S
    Miwa, K
    Sugiyama, K
    Sasaki, T
    CLINICAL & EXPERIMENTAL METASTASIS, 2000, 18 (04) : 321 - 327
  • [9] Membrane-type 1 matrix metalloproteinase enhances lymph node metastasis of gastric cancer
    Yutaka Yonemura
    Yoshio Endo
    Takahisa Takino
    Kazuki Sakamoto
    Etsurou Bandou
    Kazuo Kinoshita
    Sachio Fushida
    Kouichi Miwa
    Kazuo Sugiyama
    Takuma Sasaki
    Clinical & Experimental Metastasis, 2000, 18 : 321 - 327
  • [10] Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer
    Sato, F
    Shimada, Y
    Watanabe, G
    Uchida, S
    Makino, T
    Imamura, M
    BRITISH JOURNAL OF CANCER, 1999, 80 (09) : 1366 - 1372